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Enhanced Production of IgE Anti-
Japanese Cedar Pollen Specific
Antibodies by Peripheral Blood B Cells
from Patients with Japanese Cedar
Pollinosis
Nobuharu Ohshima1 and Shunsei Hirohata2
ABSTRACT
Background: IgE antibodies against Japanese cedar pollen (JCP) play an important role for the pathogenesis
of the cedar pollinosis, but the mechanism of their production has been unclear. We explored the capacity of
peripheral blood B cells from pollinosis patients to produce anti-JCP specific IgE.
Methods: Peripheral blood B cells from 16 pollinosis patients and 9 normal subjects were cultured with
mitomycin-C treated T cells with immobilized anti-CD3 for 10 days.
Results: B cells from pollinosis patients produced higher amounts of anti-JCP specific IgE than those from
normal subjects upon stimulation with immobilized anti-CD3 activated autologous T cell, whereas the produc-
tion of anti-JCP specific IgM were comparable between normal subjects and patients. Exogenous IL-4IL-5 or
anti-CD3 stimulated patients’ T cells could not induce the production of anti-JCP specific IgE from normal B
cells.
Conclusions: These results indicate that B cells from normal individuals contain comparable numbers of pre-
cursors that are committed to produce anti-JCP specific IgM to patients’ B cells. Moreover, the data confirm that
the class switching of IgM to IgE within anti-JCP specific B cells contributes to development of Japanese cedar
pollinosis.
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INTRODUCTION
The number of patients with Japanese cedar pollino-
sis is still increasing every year since the first report
in 1964.1 Thus, Japanese cedar pollinosis has become
one of the serious social problems in recent years,
since as many as 20% of the Japanese population are
suffering from this disease.
A number of studies have shown that IgE antibod-
ies against Japanese cedar pollen (JCP) play an im-
portant role in the pathogenesis of Japanese cedar
pollinosis.2-4 The mechanism of its production re-
mains still unclear, although it is suggested that the
production of anti-JCP specific IgE might be induced
through class-switching from IgM anti-JCP producing
B cells to IgE anti-JCP producing B cells by stimula-
tion with IL-4, IL-13 and CD40L.5,6 Comparison of the
repertoire of peripheral blood B cells against JCP be-
tween normal subjects and pollinosis patients is very
important in order to elucidate the mechanism in-
volved in production of anti-JCP specific IgE. Shin-
moto et al. recently reported that most anti-JCP-
secreting cells belong to the IgM-producing B cells in
normal subjects and even in pollinosis patients, using
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the system of transformation of B cells by EB virus.7
However, in the system of EB virus transformation,
only 0.027―0.34% of peripheral blood B cells have
been shown to be activated.8 Thus, it is likely that the
clone size of IgE anti-JCP producing B cells might be
too small to be activated by EB virus even in pollino-
sis patients. Therefore, it is still unclear whether
there might be class-switched B cells that can pro-
duce anti-JCP specific IgE in the peripheral blood of
patients with Japanese cedar pollinosis.
We have previously developed a system with im-
mobilized anti-CD3 monoclonal antibodies (mAb)
that can provide powerful stimulation of peripheral
blood B cells.9 Thus, in this system as many as 5% of
peripheral blood B cells can be stimulated to differen-
tiate into Ig producing B cells.9 This system therefore
might allow us to examine the characteristics of anti-
JCP-producing cells in peripheral B cells from normal
subjects and pollinosis patients. The current studies
were designed to examine whether peripheral blood
B cells from Japanese pollinosis patients have higher
capacity to produce anti-JCP specific IgE than those
from normal subjects.
METHODS
DETERMINATION OF IGE JCP-SPECIFIC ANTI-
BODIES (RAST)
Specific IgE antibodies to JCP in sera were deter-
mined by quantitative CAP-RAST-FEIA (Pharmacia,
Uppsala, Sweden) measurements.
PATIENTS AND SAMPLES
Peripheral blood was obtained from 16 pollinosis pa-
tients and 9 normal subjects, who gave informed con-
sent. The 16 patients consisted of 12 males aged 27―
57 (mean 34 years) and 4 females aged 26―36 (mean
31 years), and the 9 normal subjects consisted of 6
males aged 27―48 (mean 34 years) and 3 females
aged 24―26 (mean 25 years). All the 16 pollinosis pa-
tients presented sneezing, nasal congestion, andor
eye irritation during the JCP season, usually Febru-
ary through April, while none of the normal subjects
expressed any of these symptoms. All the 16 patients,
but none of the 9 normal subjects, showed positive re-
sults for JCP quantitative CAP-RAST-FEIA (Pharma-
cia, Uppsala, Sweden).
CULTURE MEDIUM AND REAGENTS
All cultures were conducted in medium RPMI 1640
(Life Technologies, Inc., Grand Island, NY, USA) sup-
plemented with penicillin G (100 Uml), streptomy-
cin (100 μgml), L-glutamine (0.3 mgml), and 10%
fetal bovine serum (Life Technologies). Cedar Pollen
Extract-Cj (Japanese cedar pollen) was purchased
from Cosmo Bio (Tokyo, Japan). 64.1, a murine IgG2a
mAb to the human CD3 molecular complex was a gift
of Dr. Peter E. Lipsky, NIAMS, Bethesda, MD, USA.
Recombinant human IL-4 and IL-5 were purchased
from Pepro Tech EC (London, UK).
CELL PREPARATION AND PURIFICATION
Peripheral blood mononuclear cells (PBMC) were
obtained by centrifugation of heparinized venous
blood over sodium diatrizoate-Ficoll gradients (Histo-
paque; Sigma Chemical Co., St. Louis, MO, USA).
PBMC were depleted of monocytes and natural killer
(NK) cells by incubation with 5 mM L-leucine methyl
ester HCl (Sigma) in serum-free RPMI 1640, as de-
scribed elsewhere.10 The treated cell population was
washed twice and then incubated with neuramini-
dase-treated sheep erythrocytes. The rosetting and
non-rosetting populations were then separated by
centrifugation on sodium diatrizoate-Ficoll gradients.
The sedimented rosetting population was treated
with isotonic NH4Cl to lyse the sheep erythrocytes,
and then was passed over a nylon-wool column to re-
move residual B cells. The T cell population con-
tained <0.1% esterase-positive monocytes and <0.5%
CD20 B cells. The non-rosetting cells obtained from
the interface were again rosetted with neuraminidase-
treated sheep erythrocytes and centrifuged on so-
dium diatrizoate-Ficoll gradients to remove residual T
cells. The resultant population of B cells contained <
1% T cells as determined by staining with anti-CD3
and anti-CD2 pan T cell mAb, followed by analysis by
flow cytometry. The cells were additionally character-
ized as containing >90% CD20-positive B cells, <1%
CD14-positive monocytes, and no CD16-positive NK
cells, as determined by flow cytometry.
CELL CULTURE TECHNIQUES OF FOR INDUC-
TION OF IG PRODUCTION
MAb 64.1 was diluted in RPMI 1640 (2 μgml), and
50 μl was placed in each well of 96-well flat bottom mi-
crotiter plates (No. 3596; Costar, Cambridge, MA,
USA) and incubated at room temperature for 2 h. The
wells were then washed once with culture medium to
remove nonadherent mAb before the cells were
added. Approximately 14―20% of the added mAb ad-
hered to the wells.11 Cultures were carried out in du-
plicated wells in a total volume of 200 μl. B cells (1 ×
105well) were cultured with autologous T cells that
had been treated with mitomycin C before culture (2
× 105well) in wells with immobilized anti-CD3, as
previously described.12 IL-4 (10 ngml) or IL-5 (10
ngml) was added where indicated. The cells were in-
cubated for 10 days at 37℃ in a humidified atmos-
phere of 5% CO2 and 95% air.
MEASUREMENT OF IGE, IGM AND IGG
The concentration of IgE, IgM and IgG was meas-
ured by ELISA. Briefly, microtiter plates (NUNC,
Roskilde, Denmark) coated with F(ab’)2 fragments of
goat anti-human IgM, IgG (Organon Teknika, Dur-
ham, NC, USA) or IgE (Chemicon, Temecula, CA,
USA) were incubated with cell-free culture superna-
IgE Anti-JCP Production by B Cells
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tants or IgM, IgG or IgE standards in PBS containing
1% bovine serum albumin (BSA; Miles, Elkhart, IN,
USA). Bound Ig were detected with peroxidase-
conjugated F(ab’)2 fragments of goat anti-human
IgM or IgG (Organon Teknika) or IgE (Biosource,
Camarillo, CA, USA) as previously described.13
MEASUREMENT OF ANTI-JCP ANTIBODIES
The concentration of anti-JCP antibodies were meas-
ured by ELISA. Briefly, wells of 96-well microtiter soft
plates (Dynatech Lab, Alexandria, VA, USA) were
coated with 50 μl solution of 10 μg proteinml Cedar
Pollen Extract-Cj (Cosmo Bio) in 0.05 M carbonate
buffer, pH 9.6, at 4℃ for overnight, and then were
overcoated with PBS containing 1% BSA at room tem-
perature for 2 h. The wells were incubated with cul-
ture supernatants, serum samples (diluted in PBS
containing 1% BSA by 1 : 20―200), or with standard
sera serially diluted in PBS containing 1% BSA, for 3
h at room temperature. Bound Ig were detected with
peroxidase conjugated F(ab’)2 fragments goat anti-
human IgE, IgG or IgM diluted with PBS containing
1% BSA (anti-IgE; 1 : 5000, anti-IgG and IgM; 1 :
20000). Development was carried out with substrate
solution containing o-phenylene diamine and H2O2,
the reaction of which was stopped by 5N H2SO4, as
previously described.14 Determination of the absor-
bance at 492 nm (OD492) was normalized to standard
sera such that anti-JCP antibodies might be con-
verted to an arbitrary unit scale. The concentration of
anti-JCP antibodies that produced half of the maximal
OD492, given by saturating concentrations of anti-
JCP in the ELISA plates, was arbitrary defined as 1
Uml.14 Nonspecific binding activities to wells with-
out Cedar Pollen Extract-Cj were also determined in
reference to the standard curves for binding activities
to Cedar Pollen Extract-Cj. The specific anti-JCP ac-
tivities were thus determined by subtracting the val-
ues for the nonspecific binding activity from those for
the binding activity to Cedar Pollen Extract-Cj. The
anti-JCP specific IgE levels in sera measured in our
ELISA were closely correlated with those obtained by
CAP-RAST-FEIA (Pharmacia, Uppsala, Sweden) (p <
0.0001, r = 0.942). The intraassay and interassay coef-
ficients of variation in our ELISA for anti-JCP specific
IgE were 7.1% and 13.8%, respectively.
RESULTS
SERUM ANTI-JCP ANTIBODIES IN PATIENTS
WITH JAPANESE CEDAR POLLINOSIS AND IN
NORMAL SUBJECTS
Initial experiments explored the serum levels of anti-
JCP antibodies using ELISA developed by us in pa-
tients with Japanese cedar pollinosis. Anti-JCP anti-
bodies were also evaluated by anti-JCP indices, calcu-
lated as anti-JCP antibodies of each isotype divided by
total corresponding immunoglobulin isotype levels.
As shown in Figure 1, there were no significant differ-
ences in serum IgE, IgG or IgM levels between polli-
nosis patients and normal subjects. In addition, there
were no significant differences in anti-JCP specific
IgM between normal subjects and pollinosis patients,
whereas serum anti-JCP specific IgE as well as anti-
JCP specific IgG were higher in pollinosis patients. Of
note, IgE and IgG anti-JCP indices were higher in pol-
linosis patients than in normal subjects, whereas
there was no significant difference in IgM anti-JCP in-
dices between the 2 groups. These results are consis-
tent with those obtained from CAP-RAST-FEIA (data
not shown). Moreover, the data also suggest that
antigen-specific IgG and IgE immune responses
might take place in pollinosis patients.
PRODUCTION OF ANTI-JCP ANTIBODIES BY
PERIPHERAL BLOOD B CELLS STIMULATED
BY IMMOBILIZED ANTI-CD3 ACTIVATED T
CELLS
Next experiments were carried out to explore
whether peripheral blood B cells from pollinosis pa-
tients have higher capacity to produce anti-JCP anti-
bodies. Highly purified peripheral blood B cells iso-
lated from normal subjects and Japanese cedar polli-
nosis patients were incubated for 10 days with mito-
mycin C treated autologous T cells in the presence of
immobilized anti-CD3. As shown in Figure 2, B cells
from pollinosis patients produced higher amounts of
anti-JCP specific IgE (p = 0.0006), but not anti-JCP
specific IgG and IgM than those from normal sub-
jects. Of note, B cells from pollinosis patients pro-
duced higher amounts of total IgE than those from
normal subjects. However, IgE anti-JCP indices were
higher in culture supernatants of pollinosis patients B
cells than in those of normal subjects B cells. There
were no significant differences in IgM and IgG anti-
JCP indices in culture supernatants between the 2
groups. These results indicate that B cells from polli-
nosis patients have higher capacities to produce total
IgE as well as anti-JCP specific IgE in response to
anti-CD3 stimulated autologous T cells. Moreover,
the data also suggested that within the IgE producing
B cells of pollinosis patients the number of JCP-
specific B cells might be increased.
TH2 CYTOKINES (IL-4, IL-5) OR T CELLS FROM
JAPANESE CEDAR POLLINOSIS PATIENTS
COULD NOT ENHANCE THE PRODUCTION OF
ANTI-JCP SPECIFIC IGE BY B CELLS FROM
NORMAL INDIVIDUALS
A number of studies have emphasized the role of T
cells, especially Th2 cells, in the elucidation of IgE re-
sponses. It was therefore possible that the enhanced
capacity of pollinosis patients B cells to produce IgE
or anti-JCP specific IgE might result from the capac-
ity of T cells to produce Th2 cytokines. To test this
point, experiments were carried out in which B cells
from normal healthy donors were cultured with mito-
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Fig. 1 Serum levels of IgE, IgG and IgM anti-Japanese cedar polen (JCP) antibodies. Sera from 9 normal individuals and 16 
patients with polinosis were assayed for total IgE, IgG and IgM levels or anti-JCP specific IgE, IgG and IgM by ELISA. Anti-JCP 
indices were calculated by anti-JCP levels of each isotype (U/ml) divided by coresponding total Ig levels (μg/ml). Data are ex-
pressed in box plots, in which horizontal lines at the top, middle, and botom of the boxes show the 75th, 50th, and 25th percen-
tiles, respectively, and vertical lines above and below the boxes show the 90th and 10th percentiles, respectively. Statistical 
significance was evaluated by Mann-Whitney’s U test.
Total IgE
U/ml U/μg
0
20
40
60
80
100
120
140
160
Normal Patient
0
2
4
6
8
10
Normal Patient
0
20
40
60
80
100
120
Normal Patient
Anti-JCP specific IgG Total IgG IgG anti-JCP indices
Normal Patient Normal Patient Normal Patient
0
50
100
150
200
250 20000
15000
10000
5000
0 0
0.005
0.01
0.015
0.02
0.025
Normal Patient
0
50
100
150
200
250
Anti-JCP specific IgM Total IgM IgM anti-JCP indices
0
500
1000
1500
2000
0
0.1
0.2
0.3
0.4
0.5
Normal Patient Normal Patient
A
B
C
P㧩0.0035 P㧩0.4523 P㧩0.0116
P㧩0.0165 P㧩0.6771 P㧩0.0022
P㧩0.9779 P㧩0.7602 P㧩0.7602
μg/ml
U/ml U/μgμg/ml
U/ml U/μgμg/ml
Anti-JCP specific IgE IgE anti-JCP indices
IgE Anti-JCP Production by B Cells
Allergology International Vol 57, No2, 2008 www.jsaweb.jp 151
Fig. 2 Production of IgE, IgG and IgM anti-Japanese cedar polen (JCP) antibodies by peripheral blood B cels. B cels 
(1×105/wel) were cultured with mitomycin C treated T cels (2×105/wel) in wels with immobilized anti-CD3 (64.1, 100 ng/wel) . 
After 10 days from the initiation of the culture, the supernatants were harvested and assayed for total IgE, IgG and IgM levels or 
anti-JCP specific IgE, IgG and IgM by ELISA. Data are expressed in box plots, in which horizontal lines at the top, middle, and 
botom of the boxes show the 75th, 50th, and 25th percentiles, respectively, and vertical lines above and below the boxes show 
the 90th and 10th percentiles, respectively. Statistical significance was evaluated by Mann-Whitney’s U test.
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Table 1 Efects of exogenous Th2 cytokines (IL-4 and IL-5) on the production of anti-JCP specific IgE and IgM.
IgM
anti-JCP
indices
(U/μg)
Total
IgM
(μg/ml)
Anti-JCP
specific
IgM
(U/ml)
IgE anti-JCP
indices
(U/μg)
Total
IgE
(μg/ml)
Anti-JCP
specific
IgE
(U/ml)
Addition
0.159 ± 0.0948.362 ± 1.7371.636 ± 1.1912.304 ± 0.6400.020 ± 0.0030.047 ± 0.016Nil
0.121 ± 0.0627.488 ± 1.0251.012 ± 0.6161.474 ± 0.4530.026 ± 0.0060.036 ± 0.009IL-4
0.182 ± 0.1178.602 ± 0.8751.763 ± 1.2621.664 ± 0.4120.025 ± 0.0030.043 ± 0.013IL-5
0.119 ± 0.0647.663 ± 0.9291.030 ± 0.6532.533 ± 1.2680.024 ± 0.0010.060 ± 0.029IL-4/IL-5
Normal B cels (1×105/wel) were cultured with mitomycin C treated normal T cels (2×105/wel) in wels with immobilized anti-CD3 (64.1, 
100 ng/wel) in the presence or absence of IL-4 (10 ng/ml) or IL-5 (10 ng/ml). After 10 days from the initiation of the culture, the supernatants 
were harvested and assayed for total IgE and IgM levels or anti-JCP specific IgE and IgM by ELISA. Mean ± SD values of 3 diferent experi-
ments are presented.
mycin C treated autologous T cells in wells with im-
mobilized anti-CD3 in the presence or absence of IL-4
and IL-5. As shown in Table 1, addition of IL-4 and IL-
5 did not enhance the production of anti-JCP specific
IgE or total IgE by B cells from normal subjects. Ac-
cordingly, addition of IL-4 and IL-5 did not signifi-
cantly increase the IgE anti-JCP indices in the culture
supernatants.
Next experiments examined whether T cells from
pollinosis patients might enhance the production of
IgE or anti-JCP specific IgE by B cells from normal
healthy subjects. B cells from normal subjects were
cultured with mitomycin-C-treated T cells from pa-
tients with cedar pollinosis in wells with immobilized
anti-CD3. However, T cells from pollinosis patients
did not enhance the production of anti-JCP specific
IgE or total IgE or IgE anti-JCP indices by B cells
from normal subjects (Fig. 3). These results indicate
that the enhanced capacity of pollinosis patients B
cells to produce anti-JCP specific IgE are due to the
abnormalities of B cell population, but not those of T
cell population. Since there was no significant differ-
ence in the capacity of B cells to produce anti-JCP
specific IgM between pollinosis patients and normal
subjects, it is suggested that pollinosis patients have a
larger number of B cells that had undergone class-
switch to be committed to produce anti-JCP specific
IgE.
DISCUSSION
In the present study, we have developed ELISA for
measurement of anti-JCP antibodies of IgM, IgG and
IgE isotypes. Anti-JCP specific IgE determined by
this ELISA correlated well with CAP-RAST-FEIA, con-
firming the reliability of this ELISA. Serum anti-JCP
specific IgE were significantly higher in pollinosis pa-
tients than in normal subjects. In addition, the ratio of
anti-JCP specific IgE to total IgE (IgE anti-JCP indi-
ces) was significantly elevated in pollinosis patients,
confirming that Cj antigen-specific IgE responses
take place in pollinosis patients. There was no differ-
ence in the binding capacity of anti-JCP specific IgE
between normal individuals and pollinosis patients.
Thus, binding curves generated by serially diluted
sera from normal individuals (OD492 values versus
dilution) were parallel to those generated by serially
diluted sera from pollinosis patients (data not
shown). It is therefore suggested that the affinity
maturation of IgE to JCP was comparable between
normal individuals and pollinosis patients.
By contrast, there were no significant differences
in anti-JCP specific IgM or IgM anti-JCP indices be-
tween pollinosis patients and normal healthy individu-
als, suggesting that there might be comparable num-
bers of B cells producing anti-JCP specific IgM in the
peripheral blood of normal healthy individuals. Of
note, serum anti-JCP specific IgG and IgG anti-JCP in-
dices were significantly elevated in pollinosis patients
compared with normal individuals. The data suggest
that anti-JCP producing B cells undergo class switch
to IgG as well as to IgE in pollinosis patients, as is
consistent with previous observations suggesting the
sequential switching from mu to epsilon via gamma
in human B cells.15-17
The results in the current studies also demon-
strated that peripheral blood B cells from normal indi-
viduals produce comparable amounts of anti-JCP spe-
cific IgM to those from pollinosis patients upon stimu-
lation with immobilized anti-CD3 stimulated autolo-
gous T cells. Moreover, IgM anti-JCP indices in the
culture supernatants of normal B cells were also com-
parable to those in the culture supernatants of polli-
nosis patients B cells. The data therefore confirm that
there are comparable numbers of B cells producing
anti-JCP specific IgM in the peripheral blood of nor-
mal individuals to that of pollinosis patients. By con-
trast, peripheral blood B cells from pollinosis patients
produced higher amounts of anti-JCP specific IgE
than those from normal individuals. Since IgE anti-
JCP indices were also higher in the culture superna-
tants of B cells from pollinosis patients, it is sug-
gested that the clone size of anti-JCP antibody pro-
ducing B cells might be expanded within IgE produc-
ing B cells in pollinosis patients.
Shinmoto and colleagues explored the capacity of
peripheral blood B cells from cedar pollinosis pa-
IgE Anti-JCP Production by B Cells
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Fig. 3 T cels from polinosis patients do not enhance the production of anti-JCP specific 
IgE by B cels from healthy donors. B cels (1×105/wel) from 5 diferent healthy donors 
were cultured with mitomycin C treated autologous T cels or T cels (2×105/wel) from one 
of 5 diferent polinosis patients in wels with immobilized anti-CD3 (64.1, 100 ng/wel). Af-
ter 10 days from the initiation of the culture, the supernatants were harvested and assayed 
for total IgE and IgM levels or anti-JCP specific IgE and IgM by ELISA. Statistical signifi-
cance was evaluated by paired sample t test.
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tients to produce antibodies to pollen antigens using
EB virus. Most of the transformed B cells produced
IgM antibodies to pollen antigens, whereas there
were no transformed B cells which produced IgE an-
tibodies to pollen antigens.7 There were no differ-
ences in the frequency to B cells to be transformed to
produce IgM antibodies against pollen antigen be-
tween healthy individuals and pollinosis patients.7
Their results are consistent with our observation that
there are comparable numbers of B cells producing
anti-JCP specific IgM in the peripheral blood of nor-
mal individuals to that of pollinosis patients. It should
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be pointed out, however, that EB virus was not potent
enough to activate B cells that are committed to pro-
duce anti-JCP specific IgE. In this regard, previous
studies demonstrated that the precursor frequency of
IgM producing B cells activated by EB virus was ap-
proximately 0.027―0.34100 B cells, which appeared
to be approximately 10% of that induced by immobi-
lized anti-CD3 stimulated CD4+ T cells (0.84―4.65
100 B cells).9 Thus, in the present study, immobilized
anti-CD3 activated T cells could induce the produc-
tion of anti-JCP specific IgE by B cells in pollinosis pa-
tients, but not in healthy individuals. These results
therefore suggest that the clone size of B cells that
produce anti-JCP specific IgE might be too small to
be activated by EB virus even in pollinosis patients.
More importantly, our system utilizing immobilized
anti-CD3 might be a powerful tool to study the regula-
tory mechanism of production of anti-JCP specific
IgE, disclosing the differences in the capacity to pro-
duce anti-JCP specific IgE by peripheral blood B cells
between pollinosis patients and normal individuals.
In our system with immobilized anti-CD3, direct in-
teractions between CD154 on activated T cells and
CD40 on B cells, as well as cytokines, including IL-2
and IL-4, have been shown to play crucial roles in B
cell differentiation.12,18-20 It should be pointed out that
an analysis using limiting dilution is necessary to cal-
culate the number of antibody-producing cells. Of
note, the results in the previous study disclosed that
the amounts of autoantibodies, such as rheumatoid
factor and anti-DNA paralleled the precursor frequen-
cies of such autoantibody producing B cells in our
system with immobilized anti-CD3.21 Therefore, it is
also likely that the number of IgE producing B cells
might be increased, although the direct demonstra-
tion with limiting dilution analysis would be required.
Although serum anti-JCP specific IgG were higher
in pollinosis patients than in normal individuals, there
were no significant differences in the capacity of pe-
ripheral blood B cells to produce anti-JCP specific
IgG between pollinosis patients and normal individu-
als. This might be accounted for by the fact that the
clone size of IgG anti-JCP producing B cells within
IgG producing B cells is too small, reflected by ex-
tremely lowever IgG anti-JCP indices compared with
IgE anti-JCP indices or IgM anti-JCP indices in the
sera as well as in the culture supernatants. It was thus
likely that even immobilized anti-CD3 stimulated T
cells could not elicit sufficient amounts of anti-JCP
specific IgG to be compared.
The results from experiments of activation of B
cells by immobilized anti-CD3 stimulated T cells con-
firm that anti-JCP producing B cells undergo class-
switch to IgE in pollinosis patients. A number of stud-
ies have disclosed that Th2 cytokines, especially IL-4,
and direct cellular interactions between T cells and B
cells might be necessary for IgE isotype switching.5,6
However, exogenous IL-4 and IL-5 did not elicit the
production of anti-JCP specific IgE by normal B cells.
Moreover, T cells from pollinosis patients could not
induce the production of anti-JCP specific IgE from
normal B cells upon stimulation with immobilized
anti-CD3. Taken together, the results indicate that ex-
ogenous Th2 cytokines and activated T cells from pol-
linosis patients would not be sufficient for IgE isotype
class switching of IgM anti-JCP producing B cells.
Steinberger and colleagues showed that allergen-
specific IgE producing B cells are not responsive to
IL-4 mediated signals.22 Thus, IL-4 and anti-IL-4 af-
fected the in vitro production of total IgE, but not that
of allergen-specific IgE, by peripheral blood B cells
from pollinosis patients.22 Accordingly, Mitchell and
colleagues also demonstrated that IL-4 promotes
polyclonal B cell activation in the in vitro system with
immobilized anti-CD3.20 Taken together, these re-
sults may have negative implications for attempts to
modulate allergen-specific IgE production in pollino-
sis patients with IL-4 antagonists. Of note, recent
studies have emphasized the role of direct cellular in-
teractions between accessory cells, including den-
dritic cells, and B cells that lead to immunoglobulin
class switching under certain circumstances.23-25 Fur-
ther studies to explore the role of such interactions in
the IgE isotype class switching would be required for
a complete understanding of the mechanism of the
IgE production.
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